EU Strategy on COVID-19 therapeutics

Author (Corporate)
Series Details COM (2021) 355
Publication Date 06/05/2021
Content Type , ,

Summary:

Communication published by the European Commission on 6 May 2021, setting out a strategy focusing on the development and availability of COVID-19 (coronavirus) therapeutics, including the treatment of the so-called long COVID condition.

Further information:

The strategy aims to cover the full lifecycle of medicines - from research, development and manufacturing to procurement and deployment. It includes a set of actions and targets on a number of fields:

  • Research, development and innovation;
  • Access to and swift approval of clinical trials;
  • Scanning for candidate therapeutics;
  • Supply chains and delivery of medicines;
  • Regulatory flexibility;
  • Joint procurement and financing;
  • International cooperation.

The strategy is seen as complementary to the EU Vaccines Strategy and part of a strong European Health Union.

On 29 June 2021, the European Commission announced the first portfolio of five therapeutics in the framework of this strategy.

Source Link Link to Main Source https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=COM:2021:355:FIN
Alternative sources
  • https://ec.europa.eu/info/files/communication-eu-strategy-covid-19-therapeutics_en
Related Links
Official
European Commission Coronavirus Response: Treatments for COVID-19 https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health_en#treatments-for-covid-19
EU EMA: Human Regulatory: Overview: COVID-19 treatments https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-treatments
European Commission: Press Release, 06/05/2021: Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics https://ec.europa.eu/commission/presscorner/detail/en/ip_21_2201
European Commission: Remarks by Commissioner Stella Kyriakides at the press conference on the EU Strategy for the development and availability of therapeutics (6 May 2021) https://ec.europa.eu/commission/presscorner/detail/en/speech_21_2328
European Commission: Press Release, 29/06/2021: COVID-19 Therapeutics Strategy: Commission identifies five promising candidate therapeutics https://ec.europa.eu/commission/presscorner/detail/en/ip_21_3299
European Commission: Questions and Answers: COVID-19 Therapeutics Strategy – list of 5 candidate therapeutics (29 June 2021) https://ec.europa.eu/commission/presscorner/detail/en/qanda_21_3301

News
Health Europa, 07/05/2021: EU Vaccine Strategy: supporting COVID-19 therapeutics development https://www.healtheuropa.eu/eu-vaccine-strategy-supporting-covid-19-therapeutics-development/108147/

Commentary and Analysis
Covington: Inside EU Life Sciences, 10/05/2021: European Commission outlines Strategy on COVID-19 Therapeutics https://www.insideeulifesciences.com/2021/05/10/european-commission-outlines-strategy-on-covid-19-therapeutics/

Subject Categories
Subject Tags
Keywords
International Organisations